A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting · NCT06857955 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients | cardiovascular disorder, hypertensive disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-09-04 | NCT06857955 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
64 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.